Oct 02, 2025 • Zacks Commentary
SOMEWHAT-BULLISH
Can Doximity's New AI Suite Drive the Growth It Needs?
DOCS reports stronger Q1 results and is betting on its new AI suite -- Scribe, GPT, and Pathway -- to drive its next growth phase.
Sep 12, 2025 • Benzinga
SOMEWHAT-BEARISH
RH Posts Downbeat Results, Joins Frequency Electronics, Tronox And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Certara ( NASDAQ:CERT ) , Abivax ( NASDAQ:ABVX )
U.S. stock futures were mixed this morning, with the Dow futures falling around 100 points on Friday. Shares of RH RH fell sharply in pre-market trading after the company posted weaker-than-expected second-quarter results after Thursday's closing bell.
Sep 02, 2025 • GlobeNewswire
NEUTRAL
Certara to Participate in Upcoming Investor Conferences
RADNOR, Pa., Sept. 02, 2025 ( GLOBE NEWSWIRE ) -- Certara, Inc. ( Nasdaq: CERT ) , a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences: ...
Sep 02, 2025 • Benzinga
NEUTRAL
Certara to Participate in Upcoming Investor Conferences - Certara ( NASDAQ:CERT )
RADNOR, Pa., Sept. 02, 2025 ( GLOBE NEWSWIRE ) -- Certara, Inc. CERT, a global leader in model-informed drug development, today announced that Company management will participate in the following investor conferences: Baird Global Healthcare Conference Date and Time: Tuesday, September 9 at ...
Aug 07, 2025 • Motley Fool
SOMEWHAT-BULLISH
Certara ( CERT ) Q2 Revenue Jumps 12%
Certara ( NASDAQ:CERT ) , a leader in biosimulation software and Model-Informed Drug Development solutions, released its Q2 FY2025 earnings on August 6, 2025. The most notable news was a slight revenue beat, with reported GAAP revenue of $104.6 million, exceeding analyst expectations, but ...
Aug 06, 2025 • Zacks Commentary
NEUTRAL
Certara, Inc. ( CERT ) Q2 Earnings Miss Estimates
Certara (CERT) delivered earnings and revenue surprises of -30.00% and +0.98%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?